1,2,4-Triazine-3,5(2H,4H)-dione,2-(2,3,5-tri-O-acetyl-b-D-ribofuranosyl)- cas no:2169-64-4
Synonyms: as-Triazine-3,5(2H,4H)-dione,2-b-D-ribofuranosyl-,2',3',5'-triacetate (7CI,8CI); 2',3',5'-Tri-O-acetyl-6-azauridine;6-Aza-2',3',5'-tri-O-acetyluridine; 6-Azauridine triacetate; Azaribin;Azaribine; CB 304; NSC 67239; Triazure
Name1,2,4-Triazine-3,5(2H,4H)-dione,2-(2,3,5-tri-O-acetyl-b-D-ribofuranosyl)-
CAS2169-64-4
Synonymsas-Triazine-3,5(2H,4H)-dione,2-b-D-ribofuranosyl-,2',3',5'-triacetate (7CI,8CI); 2',3',5'-Tri-O-acetyl-6-azauridine;6-Aza-2',3',5'-tri-O-acetyluridine; 6-Azauridine triacetate; Azaribin;Azaribine; CB 304; NSC 67239; Triazure
EINECS(EC#)218-515-6
Molecular FormulaC14H17 N3 O9
Molecular Weight371.34
refractive index1.621
Safety
Safety Information of Azaribine (CAS NO. 2169-64-4):
Safety Statements: 22-24/25
S22:Do not breathe dust
S24/25:Avoid contact with skin and eyes
WGK Germany: 2
RTECS: XY8577000
Mildly toxic by ingestion. Human systemic effects by ingestion: somnolence, convulsions or effect on seizure threshold, and cell count changes. When heated to decomposition it emits toxic fumes of NOx. Used to treat psoriasis.
1. |
|
orl-hmn TDLo:5670 mg/kg/6W:CNS,BLD
|
|
AJOGAH American Journal of Obstetrics and Gynecology. 108 (1970),272. |
2. |
|
orl-rat LD50:12 g/kg
|
|
TXAPA9 Toxicology and Applied Pharmacology. 17 (1970),511. |
3. |
|
orl-mus LD50:7800 mg/kg
|
|
TXAPA9 Toxicology and Applied Pharmacology. 17 (1970),511. |